RHY 8.57% 6.4¢ rhythm biosciences limited

The US cancer society has lowered the recommended age for bowl...

  1. 10 Posts.
    lightbulb Created with Sketch. 8
    The US cancer society has lowered the recommended age for bowl cancer screening from 50 to 45. This could benefit RHY in the future with their US GTM strategy.

    https://unauthorised investment adv...s-as-us-experts-call-for-younger-testing/amp/

    A good summary of the RHY opportunity I found on Twitter "One thing $RHY has going for it is that it has a very low market cap ($19 million, $11m EV), compared to $9,6 billion for Exact Sciences, maker of a faecal colon cancer test. Therefore, if performance is maintained in larger prospective trials, the potential is very material"
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.